HCS Software and Services Market to Expand at a CAGR of 6.9% During the Forecast Timeframe 2017–2022

0
39

The global high content screening (HCS) software and services market is foreseen to invite a host of promising opportunities while riding on technological developments in HCS solutions, cost containment in pharma research and development, and cellular research funding. Developed regions such as North America could propel the demand for HCS software and services with high government support, swelling presence of large life sciences companies, and rising research and development expenditure. HCS software and services could find application in lead specificity, the assessment of bioavailability, and qualitative assays to omit compounds with unintended modes of action.

The global HCS software and services market is foretold to expand at a CAGR of 6.9% during the forecast timeframe 2017–2022. By the end of 2022, the market could be valued at a US$1,164.8 mn. In 2017, it held a valuation of US$832.7 mn.

On the geographical front, the international HCS software and services market is envisioned to be divided into different regions such as North America, the Middle East and Africa (MEA), Latin America, Europe, and Asia Pacific except Japan (APEJ) and Japan. The analysts are of the opinion that North America could possibly lead the market with a revenue of US$426 mn expected to be achieved by the end of the forecast period.

Europe followed by Japan could be another market for HCS software and services with a strong revenue growth anticipated to be garnered by 2022. Europe is projected to reach a valuation of US$301.2 mn by the final forecast year. However, the MEA is envisaged to be on the slower side of growth throughout the course of the forecast period. Between 2017 and 2022, APEJ could create an absolute revenue prospect of US$66.3 mn.

Request for the Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=30920

The worldwide HCS software and services market could witness the presence of crucial and prominent industry players such as Thermo Fisher Scientific, Inc., General Electric Company, Becton, Dickinson & Company, PerkinElmer, Inc., Yokogawa Electric Corporation, Olympus Corporation, Merck & Co., Inc., Thorlabs, Inc., Sysmex Corporation, and Danaher Corporation.